How long can you sit on the toilet before it’s bad for your health
Did you know spending too much time sitting on the toilet could be bad for your health? I’m on @9news to explain why it could be a problem. Don’t miss it! #H…
Related Articles
Stronger networks, stronger communities
Calix delivers a broadband platform and managed services that are enabling our customers to improve life one community at a time.
Oral Muvalaplin for Lowering of Lipoprotein(a)
This randomized clinical trial assesses the effect of muvalaplin on lipoprotein(a) concentrations in patients with high baseline lipoprotein(a) levels and cardiovascular risk factors.
What’s The State of Biosimilars?
Drs. Eric Dein and Jonathan Kay discuss the state of biosimilars at the 2024 ACR Convergence meeting in Washington, DC.
Let’s reproduce GPT-2 (124M)
We reproduce the GPT-2 (124M) from scratch. This video covers the whole process: First we build the GPT-2 network, then we optimize its training to…
SUMMIT 2024: A Video Interview With Harlan Krumholz and Milton Packer | JACC | AHA 2024
Join JACC editor-in-chief Harlan M. Krumholz, MD, SM, FACC, FAHA, and JACC Senior Advisor Milton Packer, MD, FACC, as they discuss the groundbreaking SUMMIT …
Ep. 71 – Pazdur Unplugged: FDA Director Richard Pazdur on the Past, Future of Cancer Treatments
Richard Pazdur, director of FDA’s Oncology Center of Excellence, joined FDA in 1999. Looking back on his 25th anniversary, he draws a line between unpopular…
Critical Content Pediatric Critical Care Medicine, November 2024
Robert C. Tasker, MA, MBBS, MD, FRCP, RCPCH, shares the highlights of the November Pediatric Critical Care Medicine issues.Twenty-Five Years of Pediatric Cri…
Annals Animated: November 2024
This analysis of The Society of Thoracic Surgeons Database investigated risks and optimal timing for coronary artery bypass grafting (CABG). Authors categori…
ACC Cardiology Hour from AHA 2024
In this episode of ACC Cardiology Hour, Valentin Fuster, MD, PhD, MACC and the expert panelists Michael Mack, MD, MACC, Ratika Parkash, MD, MS, and…
Oral Muvalaplin for Lowering of Lipoprotein(a)
This randomized clinical trial assesses the effect of muvalaplin on lipoprotein(a) concentrations in patients with high baseline lipoprotein(a) levels and cardiovascular risk factors.